Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2022

Summary of Significant Accounting Policies

Schedule of United Kingdom research and development incentives receivable

	Current		Long-Term		Total
Balance at December 31, 2021	$	103,832	$	121,238	$	225,070
UK research and development incentives, transfer		121,238		(121,238)		—
UK research and development incentives		—		55,466		55,466
Additional 2020 incentive earned		107,906		—		107,906
UK research and development incentives cash receipt		(209,166)		—		(209,166)
Foreign currency translation		(2,572)		(4,900)		(7,472)
Balance at March 31, 2022	$	121,238	$	50,566	$	171,804

Schedule of potentially dilutive adjustments to the weighted average number of common shares excluded from the calculation

	As of March 31,
	2022	2021
Common stock purchase warrants	59,872	5,731,464
Stock options	2,195,140	1,993,804
Convertible debt	2,439,024	2,439,024
Total	4,694,036	10,164,292